358 filings
Page 9 of 18
8-K
lpjhzxqs
8 May 19
Miragen Announces First Quarter 2019 Financial Results
4:01pm
DEFA14A
5flcstf20otxn 8a9499
3 May 19
Additional proxy soliciting materials
4:46pm
8-K
i64fc
29 Apr 19
Miragen Therapeutics Announces New Data Supporting the Potential Use of Remlarsen
7:16am
8-K
91li7ezbk
26 Apr 19
Miragen Announces New Clinical Data for Cobomarsen In Atll Patients at the 19TH
7:15am
S-8
c21mk k4brr3840
14 Mar 19
Registration of securities for employees
4:16pm
8-K
ufrih57b6v 407ytum
13 Mar 19
Miragen Announces Fourth Quarter and Full Year 2018 Financial Results and Provides 2019 Outlook
4:02pm
8-K
6xwdm mx1q
8 Feb 19
Departure of Directors or Certain Officers
4:18pm
8-K
xuxvp17a22cx45cr
24 Jan 19
Entry into a Material Definitive Agreement
4:08pm
8-K
pce0l finer9unfbn47
10 Jan 19
Miragen Announces New Clinical Data In Patients with Three Different Types of Blood Cancers Treated with Cobomarsen
7:21am
8-K
belmd 0ko9uc
20 Dec 18
Other Events
7:15am
8-K
nq2ga8yr
6 Dec 18
Miragen Therapeutics Announces Board of Director Evolution and Appointment of
7:15am
8-K
r4frn
3 Dec 18
Other Events
7:16am
CT ORDER
y5g1xz7k
19 Nov 18
Confidential treatment order
1:25pm
8-K
gwp abzhdf7
7 Nov 18
Miragen Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update
4:02pm
8-K
qm1fcgilig oca
1 Oct 18
Regulation FD Disclosure
12:00am
CT ORDER
x44svw icoay2zm7
20 Aug 18
Confidential treatment order
12:00am